Latest Articles
Addition of Pembrolizumab to Chemotherapy Continues to Demonstrate Overall Survival Benefit in Advanced or Recurrent Endometrial Cancer - The ASCO Post
Addition of Pembrolizumab to Chemotherapy Continues to Demonstrate Overall Survival Benefit in Advanced or Recurrent Endometrial Cancer The ASCO Post
Published: June 3, 2026, 2:49 p.m.
Robin Quivers Announces Remission Following Endometrial Cancer Battle - sekbernews.id
Robin Quivers Announces Remission Following Endometrial Cancer Battle sekbernews.id
Published: June 3, 2026, 2:32 p.m.
Robin Quivers Announces Remission Following Extended Endometrial Cancer Battle - HarianBasis.co
Robin Quivers Announces Remission Following Extended Endometrial Cancer Battle HarianBasis.co
Published: June 3, 2026, 2:31 p.m.
Ibuprofen and endometrial cancer: An observational study finds a positive association. - unicaradio.it
Ibuprofen and endometrial cancer: An observational study finds a positive association. unicaradio.it
Published: June 3, 2026, 8:48 a.m.
NRG-GY018 at ASCO 2026: Pembrolizumab Plus Chemotherapy Sustains Overall Survival Benefit in Advanced Endometrial Cancer - Oncodaily
NRG-GY018 at ASCO 2026: Pembrolizumab Plus Chemotherapy Sustains Overall Survival Benefit in Advanced Endometrial Cancer Oncodaily
Published: June 3, 2026, 3:15 a.m.
Sacituzumab govitecan shows encouraging results for aggressive endometrial cancer - MSN
Sacituzumab govitecan shows encouraging results for aggressive endometrial cancer MSN
Published: June 3, 2026, 12:54 a.m.
GOT1 promotes endometrial cancer progression by regulating ferroptosis through the STAT3-GPX4 axis and attenuating medroxyprogesterone acetate sensitivity - Nature
GOT1 promotes endometrial cancer progression by regulating ferroptosis through the STAT3-GPX4 axis and attenuating medroxyprogesterone acetate sensitivity Nature
Published: June 2, 2026, 3:03 p.m.
Raising awareness for ovarian, endometrial cancers | 11 TV Hill - WBAL-TV
Raising awareness for ovarian, endometrial cancers | 11 TV Hill WBAL-TV
Published: June 2, 2026, 1:07 p.m.
Addition of immunotherapy shows survival benefit in follow-up trial for primary advanced or recurrent endometrial cancer - MSN
Addition of immunotherapy shows survival benefit in follow-up trial for primary advanced or recurrent endometrial cancer MSN
Published: June 2, 2026, 12:41 a.m.
Addition of immunotherapy shows survival benefit in follow-up trial for primary advanced or recurrent endometrial cancer - Medical Xpress
Addition of immunotherapy shows survival benefit in follow-up trial for primary advanced or recurrent endometrial cancer Medical Xpress
Published: June 1, 2026, 8 p.m.
Link copied to clipboard!